HDAC inhibitors could enhance the expression of cancer antigens, decrease immunosuppressive cell populations such as the myeloid-derived suppressor cells, and induce specific chemokine expression on T cells (Banik et al., 2019). This evidence concerns the gene HDAC9 and cancer.